The rising applications of CROs, including augmented reality (AR), virtual reality (VR) and mixed reality (MR) have fueled the demand for healthcare outsourcing. The adoption of ML and AI has become pronounced in the wake of increasing scrutiny to adhere to regulatory compliance of healthcare products. For instance, AI can propel transparency with accurate results and enhance the efficiency and pace of product development. Since AI is less prone to human error, it enables better quality control to bolster decision-making.

An uptick in the number of decentralized clinical trials (DCTs) in 2021 leveraged forward-looking companies to penetrate the pharmaceutical industry. The number of DCTs was forecast to be pegged at 1300 trials by 2022-end.

The report will offer a birds eye view of qualitative development/s in the healthcare outsourcing landscape. The final report, coupled with the database, will offer insights into the following dynamics:

Capacity expansion in niche markets; decoupling of service offerings; rise in safety assessment; and extended reality.

Diversifying geographical footprints and mergers acquisitions. In 2021, over 132 MAs were completed.

The expanding footprint of personalized medication, genomics and biosimilars.

IoT implementation and innovations.

Get your copy or request for a free sample of the report Healthcare Outsourcing Industry - Analysis of Top 10 Trends, compiled and published by Grand View Research.

Healthcare Outsourcing Industry Report Scope